Restricted Blood Flow Speeds Tumor Growth by Aging Immunity
Cutting off blood flow can prematurely age the bone marrow, weakening the immune system’s ability to fight cancer, according to a new study from NYU Langone...
Category : Healthcare and Pharmaceutical
First Patient Dosed in Phase III Cadonilimab Trial for Gastric CA
Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) announced the enrollment and dosing of the first patient in the pivotal Phase III clinical trial (AK104-310/COMPASSION-33) evaluating...
The Braff Group Advises Cardinal of MN on Sale to Cottages
Rochester-based Cardinal of Minnesota, which provides residential and in-home services for people with disabilities and employs about 450 people, is under new ownership as longtime CEO Jack...
OMRON Healthcare Calls for Routine At-Home BP Monitoring
Guideline Emphasis on Earlier Treatment to Reduce Health, Dementia Risks Boosts Urgency to Keep Closer Watch on Blood Pressure OMRON innovations support 2025 guidelines on...
GoodRx, Novo Nordisk Offer Ozempic, Wegovy at $499/Month
Until today, Ozempic® has not been available to eligible self-paying patients at this price GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today...
PharmaCyte Biotech Raises $7M from Existing Investors
PharmaCyte Biotech, Inc. (Nasdaq:PMCB) (“PharmaCyte” or the “Company”) announced today that it has entered into a securities purchase agreement for a $7.0 million financing with...
MedImpact Offers Low-Cost Ustekinumab Biosimilar
MedImpact Holdings Inc. today announced that it will have access to an unbranded biosimilar ustekinumab-aekn at a significantly lower cost than the reference Stelara® (ustekinumab). The...
Prenatal Pesticide Exposure Impacts Kids’ Brain, Motor Skills
Exposure during pregnancy to chlorpyrifos, a widely used pesticide, causes lasting changes in children’s brains and motor function impairments. A joint observational study by Children’s...
Centerline Biomedical Names Jim Dillon as New CEO
Centerline Biomedical, Inc. (“Centerline”), an innovative leader in cardiovascular navigation and visualization systems, announced the appointment of Jim Dillon as President and Chief Executive Officer...
Align Technology Sues Angelalign for Patent Infringement
Enforces patents representing critical components of its broad intellectual property portfolio and reflecting key investments and innovations in clear aligner therapy, including multilayer aligner material,...
FDA Clears VASTHERA to Begin Trial for PAH Drug VTB-10
On August 6, 2025, VASTHERA Co., Ltd. announced that it has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA)...
GoMo Health Launches Hub for Women, Children & Families
Holistic engagement programs offer healthcare organizations a scalable solution to support women and families in managing their physical, mental, and emotional health. GoMo Health, leader...
VantagePoint AI Flags UNH Stock Trends Before Buffett Move
Advanced technical indicators provided early warning signals before major market developments Vantagepoint A.I., LLC, a leading provider of artificial intelligence-driven market forecasting technology, announced today...
AvodahMed, Pulse4Pulse Partner on AI Preventative Care
Collaboration enhances patient outcomes, improves provider efficiency, and streamlines workflow diagnostics AvodahMed, a leader in AI-powered clinical documentation, and Pulse4Pulse (P4P), a pioneer in early detection diagnostics, today announced a technology collaboration to improve preventative care, streamline provider...
GC Biopharma, Thai Red Cross Partner on Plasma Therapies
GC Biopharma (006280.KS), a South Korean biopharmaceutical company, announced today that it has signed a Memorandum of Understanding (MOU) with the Thai Red Cross Society...